← Open Payments lookup

STEPHANIE METZGER: Open Payments

NPI 1609420942 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$540 in 19 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $502 · 2025 $540

Food & beverage: $540
CompanyPaymentsAmount
Travere Therapeutics, Inc.2$157
Calliditas Therapeutics US Inc.2$52
Ardelyx, Inc.2$39
Boehringer Ingelheim Pharmaceuticals, Inc.2$36
Corcept Therapeutics1$33
LEO Pharma Inc.1$30
AstraZeneca Pharmaceuticals LP1$27
SCPHARMACEUTICALS INC.1$25
Xeris Pharmaceuticals, Inc.1$24
Veloxis Pharmaceuticals, Inc.1$24

Products named: Filspari, TARPEYO, IBSRELA, JARDIANCE, Korlym, ANZUPGO, FARXIGA, FUROSCIX.

Industry payments across WA — which companies pay providers there.